KTM TOKAMAK OPERATION SCENARIOS SOFTWARE INFRASTRUCTURE

One of the largest problems for tokamak devices such as Kazakhstan Tokamak for Material Testing (KTM) is the operation scenarios' development and execution. Operation scenarios may be varied often, so a convenient hardware and software solution is required for scenario management and execution. Dozens of diagnostic and control subsystems with numerous configuration settings may be used in an experiment, so it is required to automate the subsystem configuration process to coordinate changes of the related settings and to prevent errors. Most of the diagnostic and control subsystems software at KTM was unified using an extra software layer, describing the hardware abstraction interface. The experiment sequence was described using a command language.The whole infrastructure was brought together by a universal communication protocol supporting various media, including Ethernet and serial links. The operation sequence execution infrastructure was used at KTM to carry out plasma experiments

Диагностические и прогностические лабораторные критерии развития сепсиса при гнойно-воспалительных заболеваниях мягких тканей

Objective. Identification of laboratory parameters that are used in routine practice and can serve as diagnostic and prognostic criteria for the development of sepsis and its outcomes in patients with purulent-inflammatory diseases of soft tissues.Materials and methods. The study included 48 patients with purulent-inflammatory diseases of soft tissues. Recorded the occurrence of such clinical events as the development of sepsis or septic shock, intensive therapy, death or recovery and discharge from the hospital. For the diagnosis of sepsis, a SOFA (Sepsis-related organ failure assessment score) ³ 2 points was used. Patients were divided into subgroups according to the number of points according to the SOFA scale, intensive care and depending on the outcome of the disease: Subgroup 1 – 26 patients with sepsis (SOFA ³ 2 points) and 22 patients with systemic inflammatory response syndrome (SIRS) and SOFA <2 points; 2nd subgroup – 12 people who underwent intensive therapy and 36 people without it; 3rd subgroup – 7 patients with a fatal outcome and 41 patients with a favorable outcome.Results. In patients with sepsis, albumin concentration was 24,07 g / l in median versus 34,65 g / l in the control group of patients with SOFA <2 points (p <0,01); glucose -7,82 mmol / l and 5,15 mmol / l (p <0,01); sodium concentration of 133 mmol / li 139 mmol / l (p <0,01). The values of the international normalized ratio (INR) amounted to a median of 1,29 and 1,04 (p <0,01); activated partial thromboplastin time -36,20 seconds and 31,50 seconds (p <0,01). In the subgroup of patients for whom intensive therapy was required, the concentration of albumin was 22,34 g / l by median versus 30,10 g / l (p <0,01); urea – 15,50 mmol / l versus 6,00 mmol / l (p <0,05), glucose – 9,61 mmol / l against 5,80 mmol / l (p <0,05), lactate dehydrogenase-644,00 U / l and 426,00 U / l (p <0,05); INR – 1,35 against 1,05 (p <0,05). The aver-age total protein concentration is 47,80 g / l versus 57,90 g / l (p <0,01). The average albumin is 22,34 g / l versus 28,50 g / l (p <0,05). The glucose concentration among patients with a fatal outcome was 12,00 mmol / l in median versus 5,95 mmol / l (p <0,01); urea – 23,22 mmol / l versus 6,00 mmol / l (p <0,01). The incidence of lethal disease was statistically significantly higher in patients with a total protein level of less than 52 g / l 5,96 times (RR = 5,96, 95% CI 1,32 – 26,89), glucose more than 11 mmol / l – 7,00 times (OR = 7,00, 95% CI 1,25 – 39,15), urea more than 20 mmol / l – 7,05 times (RR = 7,05, 95% CI 2,00 – 24,85).Conclusion. Routine laboratory indicators as the level of total protein, albumin, glucose, sodium and urea, as well as indicators of the blood coagulation system (INR and APTT), can serve as diagnostic and prognostic criteria for the development of sepsis and its outcomes in patients with purulentinflammatory diseases. soft tissue.Цель: выявление лабораторных показателей, которые используются в рутинной практике и могут служить диагностическими и прогностическими критериями развития сепсиса и его исходов у пациентов с гнойно-воспалительными заболеваниями мягких тканей.Материалы и методы. В исследование включено 48 пациентов с гнойно-воспалительными заболеваниями мягких тканей. Проводили учет наступления таких клинических событий, как развитие сепсиса или септического шока, проведение интенсивной терапии, летальный исход или выздоровление и выписка из стационара. Для постановки диагноза «сепсис» применяли шкалу SOFA (Sepsis-related organ failure assessment score) ³ 2 баллов. Пациенты были распределены в подгруппы по количеству баллов по шкале SOFA, проведения интенсивной терапии и в зависимости от исхода заболевания: 1-я подгруппа – 26 больных сепсисом (SOFA ³ 2 баллов) и 22 пациента с синдромом системного воспалительного ответа (ССВР) и SOFA < 2 баллов; 2-я подгруппа – 12 человек, которым проводилась интенсивная терапия, и 36 человек без нее; 3-я подгруппа – 7 больных с летальным исходом и 41 пациент с благоприятным исходом.Результаты. У пациентов с сепсисом концентрация альбумина составила по медиане 24,07 г/л против 34,65 г/л в контрольной группе больных с SOFA < 2 баллов (p< 0,01); глюкозы – 7,82 ммоль/л и 5,15 ммоль/л (p< 0,01); концентрация натрия 133 ммоль/л и 139 ммоль/л (p< 0,01). Значения международного нормализованного отношения (МНО) составили по медиане 1,29 и1,04 (p< 0,01); активированного частичного тромбопластинового времени – 36,20 с и 31,50 с (p< 0,01). В подгруппе пациентов, которым потребовалось проведение интенсивной терапии, концентрации альбумина составили по медиане 22,34 г/л против 30,10 г/л (p< 0,01); мочевины – 15,50 ммоль/л против 6,00 ммоль/л (p< 0,05), глюкозы– 9,61 ммоль/лпротив 5,80 ммоль/л(p< 0,05), лактатдегидрогеназы – 644,00 Ед/л и 426,00 Ед/л (p< 0,05); МНО – 1,35 против 1,05 (p< 0,05). Средняя концентрация общего белка – 47,80 г/л против 57,90 г/л (p < 0,01). Средние показатели альбумина – 22,34 г/л против 28,50 г/л (p < 0,05). Концентрация глюкозы среди пациентов с летальным исходом составила по медиане 12,00 ммоль/л против 5,95 ммоль/л (p< 0,01); мочевины – 23,22 ммоль/л против 6,00 ммоль/л (p < 0,01). Частота наступления летального исхода болезни была статистически значимо выше у пациентов с уровнем общего белка менее 52 г/л в 5,96 раз (ОР = 5,96, 95 % ДИ 1,32 – 26,89), глюкозы более 11 ммоль/л – в 7,00 раз (ОР = 7,00, 95 % ДИ 1,25 – 39,15), мочевины более 20 ммоль/л – в 7,05 раз (ОР = 7,05, 95 % ДИ 2,00 – 24,85).Заключение. Такие рутинные лабораторные показатели, как уровень общего белка, альбумина, глюкозы, натрия и мочевины, а также показатели свертывающей системы крови (МНО и АЧТВ) могут служить диагностическими и прогностическими критериями развития сепсиса и его исходов у пациентов с гнойно-воспалительными заболеваниями мягких тканей

Implementation of remote participation at Tokamak device experiments

The paper describes the software implementation of remote participation at Tokamak device experiment, particularly hardware remote control and monitoring implementation. This is an alternative to the traditional implementations based on such software kits as MDS+ and PK IVK used at Russian and foreign Tokamak devices: T-10, T-15, JET, JT-60, FTU. Traditional implementations are outdated and require deep modification for effective usage at new devices, so the new implementation is rather actual. The implementation is based on the use of new unified communication protocol for Tokamak subsystems - T-ICS. The protocol takes into account the individual peculiarities of subsystem hardware platform and provides the means of message encryption required for communication using Ethernet-based networks. The comparison of traditional approaches and the described implementation was also described. The implementation of the approach proposed was shown using a TRACE MODE SCADA for the experiment automation system hardware control at one of the foreign Tokamak devices. The use of the new implementation combined with SCADA allows significant automation of the applications development, simplifies hardware control and monitoring command language. At the present the software implementation was tested on the models of the active foreign Tokamak subsystems and it is currently used for model subsystem control. Because of the high potential of the mechanism is going to be integrated into control system of modified T-15 Russian Tokamak

Implementation of remote participation at Tokamak device experiments

The paper describes the software implementation of remote participation at Tokamak device experiment, particularly hardware remote control and monitoring implementation. This is an alternative to the traditional implementations based on such software kits as MDS+ and PK IVK used at Russian and foreign Tokamak devices: T-10, T-15, JET, JT-60, FTU. Traditional implementations are outdated and require deep modification for effective usage at new devices, so the new implementation is rather actual. The implementation is based on the use of new unified communication protocol for Tokamak subsystems - T-ICS. The protocol takes into account the individual peculiarities of subsystem hardware platform and provides the means of message encryption required for communication using Ethernet-based networks. The comparison of traditional approaches and the described implementation was also described. The implementation of the approach proposed was shown using a TRACE MODE SCADA for the experiment automation system hardware control at one of the foreign Tokamak devices. The use of the new implementation combined with SCADA allows significant automation of the applications development, simplifies hardware control and monitoring command language. At the present the software implementation was tested on the models of the active foreign Tokamak subsystems and it is currently used for model subsystem control. Because of the high potential of the mechanism is going to be integrated into control system of modified T-15 Russian Tokamak

Diagnostic and prognostic laboratory criteria for the development of sepsis in purulent-inflammatory diseases of soft tissues

Objective. Identification of laboratory parameters that are used in routine practice and can serve as diagnostic and prognostic criteria for the development of sepsis and its outcomes in patients with purulent-inflammatory diseases of soft tissues.Materials and methods. The study included 48 patients with purulent-inflammatory diseases of soft tissues. Recorded the occurrence of such clinical events as the development of sepsis or septic shock, intensive therapy, death or recovery and discharge from the hospital. For the diagnosis of sepsis, a SOFA (Sepsis-related organ failure assessment score) ³ 2 points was used. Patients were divided into subgroups according to the number of points according to the SOFA scale, intensive care and depending on the outcome of the disease: Subgroup 1 – 26 patients with sepsis (SOFA ³ 2 points) and 22 patients with systemic inflammatory response syndrome (SIRS) and SOFA <2 points; 2nd subgroup – 12 people who underwent intensive therapy and 36 people without it; 3rd subgroup – 7 patients with a fatal outcome and 41 patients with a favorable outcome.Results. In patients with sepsis, albumin concentration was 24,07 g / l in median versus 34,65 g / l in the control group of patients with SOFA <2 points (p <0,01); glucose -7,82 mmol / l and 5,15 mmol / l (p <0,01); sodium concentration of 133 mmol / li 139 mmol / l (p <0,01). The values of the international normalized ratio (INR) amounted to a median of 1,29 and 1,04 (p <0,01); activated partial thromboplastin time -36,20 seconds and 31,50 seconds (p <0,01). In the subgroup of patients for whom intensive therapy was required, the concentration of albumin was 22,34 g / l by median versus 30,10 g / l (p <0,01); urea – 15,50 mmol / l versus 6,00 mmol / l (p <0,05), glucose – 9,61 mmol / l against 5,80 mmol / l (p <0,05), lactate dehydrogenase-644,00 U / l and 426,00 U / l (p <0,05); INR – 1,35 against 1,05 (p <0,05). The aver-age total protein concentration is 47,80 g / l versus 57,90 g / l (p <0,01). The average albumin is 22,34 g / l versus 28,50 g / l (p <0,05). The glucose concentration among patients with a fatal outcome was 12,00 mmol / l in median versus 5,95 mmol / l (p <0,01); urea – 23,22 mmol / l versus 6,00 mmol / l (p <0,01). The incidence of lethal disease was statistically significantly higher in patients with a total protein level of less than 52 g / l 5,96 times (RR = 5,96, 95% CI 1,32 – 26,89), glucose more than 11 mmol / l – 7,00 times (OR = 7,00, 95% CI 1,25 – 39,15), urea more than 20 mmol / l – 7,05 times (RR = 7,05, 95% CI 2,00 – 24,85).Conclusion. Routine laboratory indicators as the level of total protein, albumin, glucose, sodium and urea, as well as indicators of the blood coagulation system (INR and APTT), can serve as diagnostic and prognostic criteria for the development of sepsis and its outcomes in patients with purulentinflammatory diseases. soft tissue

POLYMORPHISM OF THROMBOPHILIA GENES AND THEIR ROLE IN DEVELOPMENT OF DIFFERENT DISEASE PHENOTYPES AND THROMBOTIC COMPLICATIONS IN HEMOPHILIA PATIENTS

Objective was to study genetic markers of thrombophilia in patients with hemophilia, which can affect the course of the disease and contribute to thrombotic complications. Material and methods. The study included 96 patients with severe hemophilia: 75 (78.1 %) – hemophilia A, 16 (16.7 %) – hemophilia B, 5 (5.2 %) – hemophilia with inhibitor form. All patients were with severe hemophilic arthropathyand and underwent knee or hip replacement. The average age of patients was 39.6 years. All patients were examined for markers of thrombophilia. Results. Ninety three patients had either a heterozygous or homozygous form of thrombophilia marker polymorphism. One of thrombophilia markers was present in 15 (15.6 %) patients and in 78 (81.3 %) there was a combination of several markers. In patients with hemophilia B homozygous mutations in the MTHFR gene (A1298C and C677T) were more than 2 times more frequent than in patients with hemophilia A. Conclusion. The frequency of occurrence of polymorphism of FV (G1691A), MTHFR (C677T) and PAI-1 in the studied group of patients with hemophilia is higher than in the general Russian population